ICU Medical (NASDAQ:ICUI) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why

Shares of ICU Medical, Inc. (NASDAQ:ICUI) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares.

Analyst Ratings Changes

Several research firms recently commented on ICUI. Raymond James upped their target price on shares of ICU Medical from $158.00 to $190.00 and gave the company an “outperform” rating in a research note on Thursday, September 12th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Wednesday, November 13th. Finally, KeyCorp upped their target price on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research note on Wednesday, November 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

ICU Medical Stock Down 0.7 %

The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The business has a fifty day simple moving average of $163.34 and a two-hundred day simple moving average of $157.00. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of -35.23 and a beta of 0.63.

Insider Buying and Selling at ICU Medical

In other news, COO Christian B. Voigtlander sold 1,962 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total transaction of $331,734.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director David C. Greenberg sold 972 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total value of $153,682.92. Following the completion of the transaction, the director now directly owns 5,037 shares in the company, valued at $796,400.07. The trade was a 16.18 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 29,737 shares of company stock worth $4,941,832 over the last three months. Company insiders own 6.70% of the company’s stock.

Institutional Trading of ICU Medical

Hedge funds and other institutional investors have recently made changes to their positions in the business. Rhumbline Advisers increased its position in ICU Medical by 23.0% in the 2nd quarter. Rhumbline Advisers now owns 66,916 shares of the medical instruments supplier’s stock valued at $7,946,000 after acquiring an additional 12,519 shares in the last quarter. Victory Capital Management Inc. raised its position in ICU Medical by 2,966.3% in the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock worth $16,844,000 after purchasing an additional 137,222 shares during the last quarter. Arizona State Retirement System lifted its holdings in ICU Medical by 7.9% during the 2nd quarter. Arizona State Retirement System now owns 6,082 shares of the medical instruments supplier’s stock worth $722,000 after buying an additional 443 shares in the last quarter. Savant Capital LLC acquired a new stake in shares of ICU Medical in the 2nd quarter valued at $431,000. Finally, Choreo LLC bought a new stake in shares of ICU Medical during the second quarter worth $313,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.